Class information for:
Level 1: VANCOMYCIN//TEICOPLANIN//RED MAN SYNDROME

Basic class information
Class id #P Avg. number of
references		 Database coverage
of references
5145 1665 26.3 72%


Bar chart of Publication_year

Last years might be incomplete

Hierarchy of classes
The table includes all classes above and classes immediately below the current class.


Cluster id Level Cluster label #P
7 4 INFECTIOUS DISEASES//MICROBIOLOGY//VIROLOGY 1353914
73 3       MICROBIOLOGY//INFECTIOUS DISEASES//STAPHYLOCOCCUS AUREUS 82747
575 2             VANCOMYCIN//LINEZOLID//DAPTOMYCIN 14274
5145 1                   VANCOMYCIN//TEICOPLANIN//RED MAN SYNDROME 1665

Terms with highest relevance score


rank Term termType Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 VANCOMYCIN authKW 2066795 31% 22% 512
2 TEICOPLANIN authKW 1036986 10% 34% 168
3 RED MAN SYNDROME authKW 106091 1% 64% 9
4 FUNCEI address 94307 0% 86% 6
5 THERAPEUTIC DRUG MONITORING authKW 78457 6% 4% 97
6 VANCOMYCIN VCM authKW 58679 0% 80% 4
7 NON INPATIENT THERAPY authKW 55014 0% 100% 3
8 VANCOMYCIN PHARMACOKINETICS authKW 55014 0% 100% 3
9 DOSING NOMOGRAM authKW 48898 0% 67% 4
10 TROUGH CONCENTRATION authKW 48243 1% 26% 10

Web of Science journal categories


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 Pharmacology & Pharmacy 15097 55% 0% 919
2 Infectious Diseases 10540 24% 0% 400
3 Microbiology 6239 26% 0% 437
4 Medical Laboratory Technology 1441 5% 0% 85
5 Critical Care Medicine 399 3% 0% 56
6 Toxicology 383 5% 0% 88
7 Pediatrics 243 5% 0% 86
8 Urology & Nephrology 180 4% 0% 63
9 Medicine, General & Internal 165 6% 0% 105
10 Anesthesiology 107 2% 0% 31

Address terms


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 FUNCEI 94307 0% 86% 6
2 SERV CONTROL EPIDEMIOL 36676 0% 100% 2
3 SINOFRENCH PEDIAT 24449 0% 67% 2
4 CLIN INVEST CIC9202 22564 0% 31% 4
5 ADC I 18338 0% 100% 1
6 AJOU REG PHARMACOVIGILANCE 18338 0% 100% 1
7 ANESTHESIOL SURG INTENS CARE UNITS 18338 0% 100% 1
8 ANTIINFECT MED 18338 0% 100% 1
9 ARGENTEUIL MED INTENS CARE UNIT 18338 0% 100% 1
10 BACTERIOL REFERENCE ST HYLOCOCCI 18338 0% 100% 1

Journals


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY 26697 8% 1% 135
2 ANTIMICROBIAL AGENTS AND CHEMOTHERAPY 19262 9% 1% 158
3 THERAPEUTIC DRUG MONITORING 18198 4% 2% 61
4 PHARMACOTHERAPY 12156 3% 1% 55
5 INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS 8401 3% 1% 42
6 ANNALS OF PHARMACOTHERAPY 4126 2% 1% 35
7 CLINICAL PHARMACY 4020 1% 2% 13
8 MEDECINE ET MALADIES INFECTIEUSES 3492 2% 1% 27
9 HOSPITAL FORMULARY 3436 0% 2% 8
10 JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS 3054 1% 1% 19

Author Key Words


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class		 LCSH search Wikipedia search
1 VANCOMYCIN 2066795 31% 22% 512 Search VANCOMYCIN Search VANCOMYCIN
2 TEICOPLANIN 1036986 10% 34% 168 Search TEICOPLANIN Search TEICOPLANIN
3 RED MAN SYNDROME 106091 1% 64% 9 Search RED+MAN+SYNDROME Search RED+MAN+SYNDROME
4 THERAPEUTIC DRUG MONITORING 78457 6% 4% 97 Search THERAPEUTIC+DRUG+MONITORING Search THERAPEUTIC+DRUG+MONITORING
5 VANCOMYCIN VCM 58679 0% 80% 4 Search VANCOMYCIN+VCM Search VANCOMYCIN+VCM
6 NON INPATIENT THERAPY 55014 0% 100% 3 Search NON+INPATIENT+THERAPY Search NON+INPATIENT+THERAPY
7 VANCOMYCIN PHARMACOKINETICS 55014 0% 100% 3 Search VANCOMYCIN+PHARMACOKINETICS Search VANCOMYCIN+PHARMACOKINETICS
8 DOSING NOMOGRAM 48898 0% 67% 4 Search DOSING+NOMOGRAM Search DOSING+NOMOGRAM
9 TROUGH CONCENTRATION 48243 1% 26% 10 Search TROUGH+CONCENTRATION Search TROUGH+CONCENTRATION
10 LOADING DOSE 38250 1% 17% 12 Search LOADING+DOSE Search LOADING+DOSE

Core articles
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c:
(1) Number of references referring to publications in the class.
(2) Share of total number of active references referring to publications in the class.
(3) Age of the article. New articles get higher score than old articles.
(4) Citation rate, normalized to year.


Rank Reference # ref. in
cl.		 Shr. of ref. in
cl.		 Citations
1 STOCKMANN, C , ROBERTS, JK , YU, T , CONSTANCE, JE , KNIBBE, CAJ , SPIGARELLI, MG , SHERWIN, CMT , (2014) VANCOMYCIN PHARMACOKINETIC MODELS: INFORMING THE CLINICAL MANAGEMENT OF DRUG-RESISTANT BACTERIAL INFECTIONS.EXPERT REVIEW OF ANTI-INFECTIVE THERAPY. VOL. 12. ISSUE 11. P. 1371 -1388 86 65% 1
2 MOHAMMADPOUR, A , ELYASI, S , KHALILI, H , DASHTI-KHAVIDAKI, S , (2012) VANCOMYCIN-INDUCED NEPHROTOXICITY: MECHANISM, INCIDENCE, RISK FACTORS AND SPECIAL POPULATIONS. A LITERATURE REVIEW.EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY. VOL. 68. ISSUE 9. P. 1243 -1255 51 80% 62
3 VAN HAL, SJ , PATERSON, DL , LODISE, TP , (2013) SYSTEMATIC REVIEW AND META-ANALYSIS OF VANCOMYCIN-INDUCED NEPHROTOXICITY ASSOCIATED WITH DOSING SCHEDULES THAT MAINTAIN TROUGHS BETWEEN 15 AND 20 MILLIGRAMS PER LITER.ANTIMICROBIAL AGENTS AND CHEMOTHERAPY. VOL. 57. ISSUE 2. P. 734-744 39 70% 80
4 CAMPOLIRICHARDS, DM , BROGDEN, RN , FAULDS, D , (1990) TEICOPLANIN - A REVIEW OF ITS ANTIBACTERIAL ACTIVITY, PHARMACOKINETIC PROPERTIES AND THERAPEUTIC POTENTIAL.DRUGS. VOL. 40. ISSUE 3. P. 449-486 101 72% 79
5 JACQZ-AIGRAIN, E , LEROUX, S , ZHAO, W , VAN DEN ANKER, JN , SHARLAND, M , (2015) HOW TO USE VANCOMYCIN OPTIMALLY IN NEONATES: REMAINING QUESTIONS.EXPERT REVIEW OF CLINICAL PHARMACOLOGY. VOL. 8. ISSUE 5. P. 635 -648 54 67% 1
6 WILSON, APR , (1998) COMPARATIVE SAFETY OF TEICOPLANIN AND VANCOMYCIN.INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS. VOL. 10. ISSUE 2. P. 143 -152 61 90% 31
7 LEADER, WG , CHANDLER, MHH , CASTIGLIA, M , (1995) PHARMACOKINETIC OPTIMIZATION OF VANCOMYCIN THERAPY.CLINICAL PHARMACOKINETICS. VOL. 28. ISSUE 4. P. 327-342 62 87% 72
8 WILSON, APR , GRUNEBERG, RN , NEU, H , (1994) A CRITICAL-REVIEW OF THE DOSAGE OF TEICOPLANIN IN EUROPE AND THE USA.INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS. VOL. 4. ISSUE . P. S1-S30 79 74% 33
9 PAI, MP , NEELY, M , RODVOLD, KA , LODISE, TP , (2014) INNOVATIVE APPROACHES TO OPTIMIZING THE DELIVERY OF VANCOMYCIN IN INDIVIDUAL PATIENTS.ADVANCED DRUG DELIVERY REVIEWS. VOL. 77. ISSUE . P. 50 -57 40 71% 10
10 ALVAREZ, R , CORTES, LEL , MOLINA, J , CISNEROS, JM , PACHON, J , (2016) OPTIMIZING THE CLINICAL USE OF VANCOMYCIN.ANTIMICROBIAL AGENTS AND CHEMOTHERAPY. VOL. 60. ISSUE 5. P. 2601 -2609 44 63% 1

Classes with closest relation at Level 1


Rank Class id link
1 8152 BURNS TRAUMA CRIT CARE//MEROPENEM//AUGMENTED RENAL CLEARANCE
2 2737 DAPTOMYCIN//HVISA//VANCOMYCIN
3 5153 AMINOGLYCOSIDES//GENTAMICIN//AMIKACIN
4 28073 CENTRAL LINE CATHETER//EQUIPMENT DOUBLE LUMEN CARDIAC CATHETER//LEFT ATRIAL LINE
5 7142 GLYCOPEPTIDE ANTIBIOTICS//RA VII//BALHIMYCIN
6 21924 BERGMANNSTROST//BLOOD SERUM AND TISSUE CONCENTRATIONS//CENT CLIN CONCORD
7 11854 TELAVANCIN//CEFTAROLINE//LIPOGLYCOPEPTIDE
8 5963 MUPIROCIN RESISTANCE//MUPIROCIN//JOURNAL OF HOSPITAL INFECTION
9 6235 LINEZOLID//OXAZOLIDINONE//LINEZOLID RESISTANCE
10 20934 CHEMOTHERAPY DOSING//DOSE BANDING//GRANULOCYTE MACROPHAGE PROGENITOR CELLS CFU GM

Go to start page